Yongkai Cao

899 total citations · 1 hit paper
21 papers, 589 citations indexed

About

Yongkai Cao is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yongkai Cao has authored 21 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yongkai Cao's work include Receptor Mechanisms and Signaling (7 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). Yongkai Cao is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). Yongkai Cao collaborates with scholars based in China, South Korea and Bulgaria. Yongkai Cao's co-authors include Meiqun Cao, Dahua Fan, Tao Gong, Yajun Wang, Yongliang Cao, Seung Hoon Cheon, Goo Yoon, Kyeong‐Man Kim, Zengtao Wang and Srijan Acharya and has published in prestigious journals such as FEBS Letters, Biochemical Pharmacology and Signal Transduction and Targeted Therapy.

In The Last Decade

Yongkai Cao

21 papers receiving 583 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanomedicine in cancer therapy

2023 447 citations Dahua Fan, Yongkai Cao et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Yongkai Cao

Since Specialization

Citations

This map shows the geographic impact of Yongkai Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongkai Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongkai Cao more than expected).

Fields of papers citing papers by Yongkai Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongkai Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongkai Cao. The network helps show where Yongkai Cao may publish in the future.

Co-authorship network of co-authors of Yongkai Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Yongkai Cao. A scholar is included among the top collaborators of Yongkai Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongkai Cao. Yongkai Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fluid-based biomarkers for neurodegenerative diseases 2025 ·Ageing Research Reviews ·Yongliang Cao, (unknown), Yifei Xu, Meiqun Cao, Nan Chen, Qiuming Zeng, Mitchell K.P. Lai, Dahua Fan, Gautam Sethi, Yongkai Cao	9
2	Exosomal miR-125b-5p derived from mesenchymal stromal/stem cell enhances anti-PD-1 therapy in mouse colon cancer model 2025 ·Stem Cell Research & Therapy ·Mengmeng Jiang, (unknown), Shengquan Hu, (unknown), Yongkai Cao, Zhengzhi Wu	3
3	Mdm2‐mediated ubiquitination of PKCβII is responsible for insulin‐induced heterologous desensitization of dopamine D ₃ receptor 2024 ·FEBS Letters ·(unknown), (unknown), Yongkai Cao, (unknown), Xiaohan Zhang	1
4	TRAF6-mediated ubiquitination of AKT1 in the nucleus occurs in a β-arrestin2-dependent manner upon insulin stimulation 2024 ·Biochemical Pharmacology ·Li Hu, Haiping Liu, (unknown), (unknown), Yongkai Cao, Bing Liu, Hui‐Jun Li, Xiaohan Zhang	1
5	TRAF6-mediated ubiquitination of AKT in the nucleus is a critical event underlying the desensitization of G protein-coupled receptors 2024 ·Cell Communication and Signaling ·(unknown), Li Hu, Bing Liu, (unknown), (unknown), Yongkai Cao, Hui‐Jun Li, Xiaohan Zhang	3
6	Comparative study of the molecular mechanisms underlying the G protein and β‐arrestin‐dependent pathways that lead to ERKs activation upon stimulation by dopamine D ₂ receptor 2023 ·FEBS Journal ·Haiping Liu, Srijan Acharya, Sarabjeet Kour Sudan, Li Hu, (unknown), Yongkai Cao, Hui‐Jun Li, Xiaohan Zhang	4
7	A novel colchicine-myricetin heterozygous molecule: design, synthesis, and effective evaluations on the pathological models of acute lung injury in vitro and in vivo 2023 ·Frontiers in Pharmacology ·Zhiyue Li, (unknown), Jiangchun Wei, (unknown), Guanbao Zhu, Yongkai Cao, (unknown), Yaqian Liu, Yan Li, Limin Li, Xinping Li, Zhengzhi Wu	1
8	Nanomedicine in cancer therapy breakdown → 2023 ·Signal Transduction and Targeted Therapy ·Dahua Fan, Yongkai Cao, Meiqun Cao, Yajun Wang, Yongliang Cao, Tao Gong	447
9	Design, synthesis and biological evaluation of a novel colchicine-magnolol hybrid for inhibiting the growth of Lewis lung carcinoma in Vitro and in Vivo 2022 ·Frontiers in Chemistry ·Zhiyue Li, Shengquan Hu, (unknown), Ziwen Li, Guanbao Zhu, Yongkai Cao, Limin Li, (unknown), (unknown), Xinping Li, Guangjie Liu, Keji Chen, Zhengzhi Wu	1
10	Licochalcone E improves insulin sensitivity in palmitic acid-treated HepG2 cells through inhibition of the NLRP3 signaling pathway 2021 ·International Immunopharmacology ·Yongkai Cao, (unknown), Meifen Li, Dahua Fan, Meiqun Cao, Seung Hoon Cheon, Jian Liang, Pei Lu	6
11	Recombinant ling zhi-8 enhances Tregs function to restore glycemic control in streptozocin-induced diabetic rats 2020 ·Journal of Pharmacy and Pharmacology ·(unknown), Zhi Fang, (unknown), Ping Ding, Yongkai Cao, (unknown), Shaozhen Hou, Jian Liang	5
12	Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D₃ receptor agonists 2018 ·MedChemComm ·Yongkai Cao, Ningning Sun, (unknown), Zhiguo Liu, Yizhe Tang, Zhengzhi Wu, Kyeong‐Man Kim, Seung Hoon Cheon	11
13	Antidiabetic effect of SN158 through PPARα/γ dual activation in ob/ob mice 2017 ·Chemico-Biological Interactions ·Yujung Jung, Yongkai Cao, (unknown), Goo Yoon, Seung Hoon Cheon, Gyu‐Un Bae, (unknown), Yong Kee Kim, Su‐Nam Kim	8
14	A Novel Partial PPARα/γ Dual Agonist SN159 Improves Insulin Sensitivity 2016 ·Bulletin of the Korean Chemical Society ·Yujung Jung, Yongkai Cao, (unknown), Ki Hyun Kim, Goo Yoon, Seung Hoon Cheon, Jee‐Young Lee, Su‐Nam Kim, Yong Kee Kim	3
15	Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands 2015 ·Bioorganic & Medicinal Chemistry ·Yongkai Cao, Chengchun Min, Srijan Acharya, Kyeong‐Man Kim, Seung Hoon Cheon	15
16	Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands 2015 ·Bioorganic & Medicinal Chemistry ·Yongkai Cao, (unknown), Xiaowei Zhang, Kyeong‐Man Kim, Seung Hoon Cheon	6
17	Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors 2015 ·Bioorganic & Medicinal Chemistry ·(unknown), Yongkai Cao, (unknown), (unknown), Kyeong‐Man Kim, Seung Hoon Cheon	13
18	Concise synthesis of licochalcone C and its regioisomer, licochalcone H 2013 ·Archives of Pharmacal Research ·Zengtao Wang, Yongkai Cao, (unknown), Goo Yoon, Seung Hoon Cheon	26
19	Short and Efficient Synthesis of Licochalcone B and D Through Acid-Mediated Claisen-Schmidt Condensation 2013 ·Bulletin of the Korean Chemical Society ·Zengtao Wang, Zhiguo Liu, Yongkai Cao, (unknown), Goo Yoon, Seung Hoon Cheon	14
20	Structural elucidation of Pogostone and its dimers-two novel diastereomers combined with X-ray diffraction and spectroscopy 2013 ·Journal of Molecular Structure ·(unknown), Chuwen Li, Yongkai Cao, Yuyang Yi, (unknown), Xue-Xuan Feng, Ziren Su, Huifang Zeng	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact